FDA Commissioner Dr. Marty Makary debunks myths about FDA staffing changes - w' Megyn Kelly

FDA Commissioner Dr. Marty Makary, in a candid interview with Megyn Kelly, debunks myths about FDA staffing changes: The FDA’s top priority is delivering cures, effective treatments, and healthier foods for Americans.

Despite media claims of “cuts” threatening safety, Dr. Makary clarifies no scientists, reviewers, inspectors, or law enforcement were let go. Reductions focused on administrative roles—communications, IT, and legislative affairs—where efficiencies were critical.

Here’s the truth: FDA staff doubled from 9,500 in 2006 to 18,000 under the Biden admin. Recent reductions of ~3,500 were mostly early retirements, not firings of key experts.

Dr. Makary calls out misleading reports that ignore this context, saying, “Failing to note the 100% staff increase since 2006 is dishonest.” His team has even invited back high-performing retirees to maintain expertise.

Dr. Makary’s mission? Ensuring FDA scientists and inspectors have every resource to speed up safe drug approvals and protect public health.

WATCH THE FULL PODCAST: Medical Establishment Keeps Us Sick, Censorship, w/ Makary & Ravikant - Megyn Kelly https://rumble.com/v5dymyh-medical-establishment-keeps-us-sick-censorship-w-makary-and-ravikant-megyn-.html?mref=1bxo9j&mc=69gy3